HomeWebcastEmerging Antitrust Issues in Pharmaceuticals and Life Sciences Sectors
Online CLE Antitrust Issues CLE

Emerging Antitrust Issues in Pharmaceuticals and Life Sciences Sectors

Live Webcast Date: Tuesday, November 19, 2019 from 12:00 pm to 2:00 pm (ET)
CLE AntitrustLive Webcast
Listen Live/On-Demand
Add to Calendar 11/19/2019 11:00 am 11/19/2019 2:00 pm America/New_York The Knowledge Group Webinar: Emerging Antitrust Issues in Pharmaceuticals and Life Sciences Sectors The event starts in an hour. If you have not registered, please go to the link below to sign up today.https://www.theknowledgegroup.org/checkout/?add-to-cart=132483\r\n Antitrust violations in the pharmaceutical and life sciences industry continue to proliferate in recent years, resulting to intensified enforcement actions and increased litigation. Issues on pricing transparency, complex distribution chain, and third-party payers are significant factors contributory to this upward trend. Compliance has never been more critical. \n \nTo mitigate compliance issues and challenges, it is imperative that counsel to businesses are in the know of the latest trends and developments in this evolving regulatory paradigm. They must be able to identify effective strategies to guide their clients from further antitrust disputes. \n \nJoin a panel of key thought leaders and practitioners assembled by The Knowledge Group as they provide an in-depth discussion of the emerging antitrust enforcement actions in the pharmaceutical and life sciences industry. Speakers will dig deeper as they offer risk mitigations strategies and best practices in this increasingly complex legal climate. \n \nThis LIVE Webcast will discuss the following: \n \n \n Antitrust Issues and Disputes - Statistics \n Emerging Regulatory Enforcement Actions \n Risk Mitigation Techniques \n Best Compliance Practices \n What Lies Ahead \n \n https://www.theknowledgegroup.org/webcasts/pharmaceuticals-and-life-sciences-sector/

Online CLE Antitrust Issues

Antitrust violations in the pharmaceutical and life sciences industry continue to proliferate in recent years, resulting to intensified enforcement actions and increased litigation. Issues on pricing transparency, complex distribution chain, and third-party payers are significant factors contributory to this upward trend. Compliance has never been more critical.

To mitigate compliance issues and challenges, it is imperative that counsel to businesses are in the know of the latest trends and developments in this evolving regulatory paradigm. They must be able to identify effective strategies to guide their clients from further antitrust disputes.

Join a panel of key thought leaders and practitioners assembled by The Knowledge Group as they provide an in-depth discussion of the emerging antitrust enforcement actions in the pharmaceutical and life sciences industry. Speakers will dig deeper as they offer risk mitigations strategies and best practices in this increasingly complex legal climate.

This LIVE Webcast will discuss the following:

  • Antitrust Issues and Disputes - Statistics
  • Emerging Regulatory Enforcement Actions
  • Risk Mitigation Techniques
  • Best Compliance Practices
  • What Lies Ahead

Agenda

Howard Morse, Partner
Cooley LLP

Andrew J. Forman, Partner
Paul Weiss

Who Should Attend

  • Antitrust Lawyers
  • Healthcare and Pharma Lawyers
  • Health and Pharma Professionals
  • Pharmaceutical and Healthcare Industries
  • Litigation Officers
  • Business Developers
  • Business Executives
  • General Counsel in Life Sciences and Healthcare Industries
  • Chief Compliance Officers
  • Drug Manufacturing Executives
  • Pharmaceutical Companies
  • Other related/interested professionals and organizations

Online CLE Antitrust Issues

Howard Morse, Partner
Cooley LLP

Andrew J. Forman, Partner
Paul Weiss

Online CLE Antitrust Issues

Online CLE Antitrust Issues

Howard MorsePartnerCooley LLP

Howard Morse is a Washington, DC-based partner in Cooley's Antitrust & Competition practice group. He represents businesses before the Department of Justice, Federal Trade Commission, and state attorneys general in investigations of mergers, acquisitions and joint ventures, as well as alleged monopolization, restraint of trade and unfair and deceptive practices. Howard has been at the forefront of applying antitrust law to the high-tech sector and the intersection of antitrust and intellectual property law, and regularly represents clients in technology, life sciences and other high-tech industries.

Before joining Cooley, Howard served for 10 years at the FTC, where he was Assistant Director of the Bureau of Competition and responsible for more than 50 enforcement actions. In the private sector, Howard has recently represented Rovi in its $1.1 billion acquisition of Tivo, combining two media and entertainment innovators, and Zeltiq in its $2.5 billion sale to Allergan, combining leaders in medical aesthetics.

Online CLE Antitrust Issues

Andrew J. FormanPartnerPaul Weiss

A partner in the Antitrust Group, Andy Forman focuses his practice on counseling clients in a wide range of antitrust matters, with an emphasis on mergers and acquisitions, joint ventures and investigations by the U.S. Department of Justice and U.S. Federal Trade Commission. Throughout his career, Andy has represented numerous leading companies including Cigna, Eli Lilly & Company, Goodyear Tire and Rubber Co., Microsoft Corporation, Pfizer Inc., Salix Pharmaceuticals, Ltd., Smith & Nephew and US Airways Inc.

Andy previously worked for the FTC’s Bureau of Competition (Mergers I), where he helped lead antitrust investigations in large mergers and acquisitions in the pharmaceutical, medical device, consumer products, industrial products and aircraft components industries.  He has been recognized by The Legal 500Benchmark Litigation and The Best Lawyers in America. Andy received a J.D. from Georgetown University Law Center and a B.A. from Washington University. He has worked on multiple matters that won the Global Competition Review’s antitrust matter of the year.

Online CLE Antitrust Issues

Course Level:
   Intermediate

Advance Preparation:
   Print and review course materials

Method Of Presentation:
   Live Webcast

Prerequisite:
   General knowledge of antitrust laws

Course Code:
   148316

NY Category of CLE Credit:
   Areas of Professional Practice

Total Credits:
    2.0 CLE

No Access

You are not logged in. Please or register to the event to gain access to the materials and login instructions.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

About the Knowledge Group

The Knowledge Group

The Knowledge Group has been a leading global provider of Continuing Education (CLE, CPE) for over 13 Years. We produce over 450 LIVE webcasts annually and have a catalog of over 4,000 on-demand courses.

Cooley’s attorneys solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. Cooley has 900 lawyers across 12 offices in the United States, China and Europe. Cooley's antitrust & competition team is recognized as one of the top-tier practices in the area of antitrust by Legal 500, Chambers USA and Global Competition Review. We handle all aspects of antitrust and competition law matters – including counseling, litigation, agency representation and arbitration services – for Fortune 500 corporations, as well as growing companies.

Website: https://www.cooley.com/

Paul, Weiss (www.paulweiss.com) is a firm of more than 1,000 lawyers with diverse backgrounds, personalities, ideas and interests who provide innovative and effective solutions to our clients’ most complex legal and business challenges. We take great pride in representing the world’s leading companies in their critical legal matters and most significant business transactions, as well as individuals and organizations in need of pro bono assistance.

Website: http://www.paulweiss.com/

Howard Morse is a Washington, DC-based partner in Cooley's Antitrust & Competition practice group. He represents businesses before the Department of Justice, Federal Trade Commission, and state attorneys general in investigations of mergers, acquisitions and joint ventures, as well as alleged monopolization, restraint of trade and unfair and deceptive practices. Howard has been at the forefront of applying antitrust law to the high-tech sector and the intersection of antitrust and intellectual property law, and regularly represents clients in technology, life sciences and other high-tech industries.

Before joining Cooley, Howard served for 10 years at the FTC, where he was Assistant Director of the Bureau of Competition and responsible for more than 50 enforcement actions. In the private sector, Howard has recently represented Rovi in its $1.1 billion acquisition of Tivo, combining two media and entertainment innovators, and Zeltiq in its $2.5 billion sale to Allergan, combining leaders in medical aesthetics.

A partner in the Antitrust Group, Andy Forman focuses his practice on counseling clients in a wide range of antitrust matters, with an emphasis on mergers and acquisitions, joint ventures and investigations by the U.S. Department of Justice and U.S. Federal Trade Commission. Throughout his career, Andy has represented numerous leading companies including Cigna, Eli Lilly & Company, Goodyear Tire and Rubber Co., Microsoft Corporation, Pfizer Inc., Salix Pharmaceuticals, Ltd., Smith & Nephew and US Airways Inc.

Andy previously worked for the FTC’s Bureau of Competition (Mergers I), where he helped lead antitrust investigations in large mergers and acquisitions in the pharmaceutical, medical device, consumer products, industrial products and aircraft components industries.  He has been recognized by The Legal 500Benchmark Litigation and The Best Lawyers in America. Andy received a J.D. from Georgetown University Law Center and a B.A. from Washington University. He has worked on multiple matters that won the Global Competition Review’s antitrust matter of the year.

Ultimate Value Annual Program

Bring a colleague for only $149, a savings of $50 per additional attendee.

  • Unlimited Access to Live & Recorded Webcasts
  • Instant Access to Course Materials
  • And More!

$199